Federated Hermes, Inc. Clearside Biomedical, Inc. Transaction History

Federated Hermes, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.08 - $1.83 $74 - $126	69 New	69 $1,000
Q4 2021 Feb 14, 2022	SELL	$2.72 - $5.72 $179 - $377	-66 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $318 - $475	66 New	66 $1,000
Q2 2021 Aug 16, 2021	SELL	$2.32 - $5.38 $1,883 - $4,368	-812 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$2.24 - $4.25 $1,818 - $3,451	812 New	812 $2,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.